Common use of Grant of Option Clause in Contracts

Grant of Option. This agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 5 contracts

Sources: Incentive Stock Option Agreement (Demandware Inc), Incentive Stock Option Agreement (Demandware Inc), Incentive Stock Option Agreement (Demandware Inc)

Grant of Option. This agreement evidences the grant by DemandwareIcagen, Inc., a Delaware corporation (the “Company”), on , 20 200 (the “Grant Date”) to , a UK resident an [employee], consultant or director [consultant], [director] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 4 contracts

Sources: Nonstatutory Stock Option Agreement (Icagen Inc), Nonstatutory Stock Option Agreement (Icagen Inc), Nonstatutory Stock Option Agreement (Icagen Inc)

Grant of Option. This agreement evidences the grant by DemandwareEditas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ ], a UK resident an employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 4 contracts

Sources: Nonstatutory Stock Option Agreement (Editas Medicine, Inc.), Nonstatutory Stock Option Agreement (Editas Medicine, Inc.), Nonstatutory Stock Option Agreement (Editas Medicine, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareStarent Networks, Inc.Corp., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Non Employee Director Nonstatutory Stock Option Agreement (Starent Networks, Corp.), Non Employee Director Nonstatutory Stock Option Agreement (Starent Networks, Corp.)

Grant of Option. This agreement evidences the grant by DemandwareKolltan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on February 27, 20 2009 (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock 2008 Equity Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stockCommon Stock, $0.01 .001 par value per sharevalue, of the Company (“Common Stock”) at $ $0.10 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Kolltan Pharmaceuticals Inc), Incentive Stock Option Agreement (Kolltan Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by DemandwareTetraphase Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ a price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Tetraphase Pharmaceuticals Inc), Incentive Stock Option Agreement (Tetraphase Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by Demandware, Blackboard Inc., a Delaware corporation (the “Company”), on [Date], 20 (the “Grant Date”) to [Name], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of [Number] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Blackboard Inc), Incentive Stock Option Agreement (Blackboard Inc)

Grant of Option. This agreement evidences the grant by DemandwareSyros Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ ], 20 (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Equity Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Syros Pharmaceuticals, Inc.), Incentive Stock Option Agreement (Syros Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAVEO Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2010 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 .001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement, Incentive Stock Option Agreement (Aveo Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by DemandwareStream Global Services, Inc., a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2008 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ], 20 20[ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Stream Global Services, Inc.), Incentive Stock Option Agreement (Stream Global Services, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Blackboard Inc., a Delaware corporation (the “Company”), on , 20 [Date] (the “Grant Date”) to [Name], a UK resident an employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of [Number] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Nonstatutory Stock Option Agreement (Blackboard Inc), Nonstatutory Stock Option Agreement (Blackboard Inc)

Grant of Option. This agreement evidences the grant by DemandwareCasa Systems, Inc., a Delaware corporation (the “Company”), on May 25, 20 2012 (the “Grant Date”) to ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, a UK resident an employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2011 Stock Incentive Plan (the “Plan”), a total of 40,000 shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ 16.92 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on May 24, 20 2022 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Consulting Agreement (Casa Systems Inc), Consulting Agreement (Casa Systems Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident employee, consultant or director an employee of a subsidiary to the Company or one of its subsidiaries or affiliates (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Demandware Inc), Incentive Stock Option Agreement (Demandware Inc)

Grant of Option. This agreement evidences the grant by DemandwareTransMedics, Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement, Incentive Stock Option Agreement (TransMedics, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareDurata Therapeutics, Inc., a Delaware corporation (the “Company”), on , 20 2012 (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Share.1 Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). Date”).2 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 2 contracts

Sources: Incentive Stock Option Agreement (Durata Therapeutics, Inc.), Incentive Stock Option Agreement (Durata Therapeutics, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAgios Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident an employee, consultant consultant, or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Agios Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by DemandwareIdera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2008 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Idera Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Inc.The First Marblehead Corporation, a Delaware corporation (the "Company"), on , 20 200 (the "Grant Date") to , a UK resident an [employee], consultant or director [consultant], [director] of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's 2003 Stock Incentive Plan (the "Plan"), a total of shares (the "Shares") of common stock, $0.01 .01 par value per share, of the Company ("Common Stock") at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (First Marblehead Corp)

Grant of Option. This agreement evidences the grant by Demandware, Inc.MicroStrategy Incorporated, a Delaware corporation (the CompanyMicroStrategy”), on , 20 20[ ] (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company [ ] (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the CompanyMicroStrategy’s 2012 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of class A common stock, $0.01 0.001 par value per share, of the Company MicroStrategy (“Common Stock”) at [$ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Microstrategy Inc)

Grant of Option. This agreement evidences the grant by DemandwareStemline Therapeutics, Inc., a Delaware corporation (the “Company”), on , 20 201 (the “Grant Date”) to , a UK resident an employee, consultant or and/or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Equity Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Stemline Therapeutics Inc)

Grant of Option. This agreement evidences the grant by DemandwareCELLYNX, Inc.INC., a Delaware California corporation (the “Company”), on May 20, 20 2008 (the “Grant Date”) to ▇▇▇▇▇▇ ▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of 6,737,448 shares (the “Shares”) of common stock, $0.01 no par value per share, of the Company (“Common Stock”) at $ $0.099 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the fifth anniversary of this Agreement (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Norpac Technologies, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareCambridge Heart, Inc., a Delaware corporation (the “Company”), in lieu of a 2009 cash bonus, on March , 20 2010 (the “Grant Date”) to , a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2001 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 .001 par value per share, of the Company (“Common Stock”) at $ per ShareShare (the “Option”). Unless earlier terminated, this option Option shall expire at 5:00 p.m.on March , Eastern time, on , 20 2020 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”), to the maximum extent permitted by the Code. Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Cambridge Heart Inc)

Grant of Option. This agreement evidences the grant by DemandwareHybridon, Inc., a Delaware corporation (the “Company”), on ______ ___, 20 (the 200___(the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2005 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [______] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Hybridon Inc)

Grant of Option. This agreement evidences the grant by DemandwareSongzai International Holding Group, Inc., a Delaware Nevada corporation (the “Company”), on , 20 _____ (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company ▇▇▇▇ ▇▇▇▇▇ (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2009 Stock Incentive Plan (the “Plan”), a total of 20,000 shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ per Sharethe Fair Market Value (as such term is defined in the Plan) on the Grant Date. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 _____ (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Non Statutory Stock Option Agreement (Songzai International Holding Group Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.454 Life Sciences Corporation, a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock 2006 Equity Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Curagen Corp)

Grant of Option. This agreement evidences the grant by DemandwareBioSphere Medical, Inc., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [_______] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Biosphere Medical Inc)

Grant of Option. This agreement evidences the grant by DemandwareStarent Networks, Inc.Corp., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Starent Networks, Corp.)

Grant of Option. This agreement (this “Agreement”) evidences the grant by DemandwareZipcar, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2011 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this optionAgreement, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Director Nonstatutory Stock Option Agreement (Zipcar Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Voyager Pharmaceutical Corporation, a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2005 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Voyager Pharmaceutical Corp)

Grant of Option. This agreement evidences the grant by DemandwareNitroSecurity, Inc., a Delaware corporation (the “Company”), on February 21, 20 2005 (the “Grant Date”) to S▇▇▇ ▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2005 Stock Incentive Plan (the “Plan”), a total of 100,000 shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $0.15 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on February 20, 20 2015 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (NitroSecurity, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), on , 20 201[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2014 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.00005 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Brainstorm Cell Therapeutics Inc.)

Grant of Option. This agreement evidences the grant by DemandwareConstant Contact, Inc., a Delaware corporation (the “Company”), on ___, 20 200[ ] (the “Grant Date”) to [_____], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of [_____] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[_____] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [_______] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Constant Contact, Inc.)

Grant of Option. This agreement evidences the grant by Demandware▇▇▇▇▇▇ Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on February 26, 20 2017 (the “Grant Date”) to ▇▇▇▇▇ ▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2011 Stock Incentive Plan (the “Plan”), a total of 182,168 shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $0.96 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on February 25, 20 2027 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Employment Agreement (Allena Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAlnylam Pharmaceuticals, Inc.Inc,, a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2009 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 .0001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Alnylam Pharmaceuticals, Inc.)

Grant of Option. This agreement (this "Agreement") evidences the grant by DemandwareZipcar, Inc., a Delaware corporation (the "Company"), on _________ , 20 20__ (the "Grant Date") to , a UK resident employee, consultant or director an employee of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's 2011 Stock Incentive Plan (the "Plan"), a total of shares (the "Shares") of common stock, $0.01 0.001 par value per share, of the Company ("Common Stock") at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the tenth anniversary of the Grant Date (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this optionAgreement, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Zipcar Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.The First Marblehead Corporation, a Delaware corporation (the “Company”), on , 20 200 (the “Grant Date”) to , a UK resident an [employee], consultant or director [consultant], [director] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2003 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (First Marblehead Corp)

Grant of Option. (a) This agreement evidences the grant by Demandware, Inc.The Medicines Company, a Delaware corporation (the “Company”), on , 20 2004 (the “Grant Date”) to , a UK resident an [employee], consultant or director [consultant] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company share (“Common Stock”) ), of the Company at a price of $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the tenth anniversary of the Grant Date (the “Final Exercise Date”). . (b) It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, amended and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Medicines Co /De)

Grant of Option. This agreement evidences the grant by Demandware, Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), on , 20 200[___] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan Plan, as amended (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Cornerstone Therapeutics Inc)

Grant of Option. This agreement evidences the grant by DemandwareConcert Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Amended and Restated 2006 Stock Incentive Option and Grant Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value $0.001 per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Concert Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on , 20 20__ (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 20__ (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Demandware Inc)

Grant of Option. This agreement evidences the grant by DemandwareAchillion Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on [ ], 20 (the “Grant Date”) to to[ ], a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Achillion Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Southern Trust Securities Holding Corp., a Delaware Florida corporation (the “Company”"Corporation"), on October 1, 20 2010 (the "Grant Date") to ▇▇▇▇▇ ▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a wholly-owned subsidiary to of the Company Corporation (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of Three Hundred Thousand (300,000) shares (the "Shares") of restricted common stock, $0.01 par value per share, stock of the Company Corporation ("Common Stock") at $ $.25 per ShareShare (the "Exercise Price"). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on October 1, 20 2020 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Southern Trust Securities Holding Corp)

Grant of Option. This agreement evidences the grant by DemandwareIBuyDigital, Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (IBuyDigital.com, Inc.)

Grant of Option. This agreement (this “Agreement”) evidences the grant by DemandwareVerastem, Inc., a Delaware corporation (the “Company”), on , 20 date (the “Grant Date”) to Employee Name, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of number shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ $price per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Verastem, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareNetwork Engines, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident an [employee], consultant or director [consultant], [director] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock 2009 Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Network Engines Inc)

Grant of Option. This agreement evidences the grant by DemandwareAlnylam Pharmaceuticals, Inc.Inc,, a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2009 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Alnylam Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware▇▇▇▇▇▇, Inc., Inc. a Delaware corporation (the “Company”), on May 5, 20 2006 (the “Grant Date”) to ▇▇▇▇▇▇ ▇▇▇▇▇▇, a UK resident employee▇▇., consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of 75,000 shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $3.40 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on May 5, 20 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Nestor Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Southern Trust Securities Holding Corp., a Delaware Florida corporation (the “Company”"Corporation"), on October 1, 20 2010 (the "Grant Date") to ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a wholly-owned subsidiary to of the Company Corporation (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of Three Hundred Thousand (300,000) shares (the "Shares") of restricted common stock, $0.01 par value per share, stock of the Company Corporation ("Common Stock") at $ $.25 per ShareShare (the "Exercise Price"). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on October 1, 20 2020 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Southern Trust Securities Holding Corp)

Grant of Option. This agreement evidences the grant by DemandwareTier Technologies, Inc., a Delaware California corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Amended and Restated 2004 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of Class B common stock, $0.01 no par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Tier Technologies Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Southern Trust Securities Holding Corp., a Delaware Florida corporation (the “Company”"Corporation"), on October 1, 20 2010 (the "Grant Date") to ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a wholly-owned subsidiary to of the Company Corporation (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of Three Hundred Thousand (300,000) shares (the "Shares") of restricted common stock, $0.01 par value per share, stock of the Company Corporation ("Common Stock") at $ $.25 per ShareShare (the "Exercise Price"). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on October 1, 20 2020 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Southern Trust Securities Holding Corp)

Grant of Option. This agreement evidences the grant by Demandware▇▇▇▇▇▇, Inc., Inc. a Delaware corporation (the “Company”), on November 1, 20 2006 (the “Grant Date”) to ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of 25,000 shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $2.16 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on November 1, 20 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Nestor Inc)

Grant of Option. This agreement evidences the grant by Demandware, Emergent BioSolutions Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] [ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Emergent BioSolutions Inc.)

Grant of Option. This agreement evidences the grant by DemandwareNitroSecurity, Inc., a Delaware corporation (the “Company”), on July 1, 20 2005 (the “Grant Date”) to T▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2005 Stock Incentive Plan (the “Plan”), a total of 1,050,000 shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $0.15 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on June 30, 20 2015 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (NitroSecurity, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAmeresco, Inc., a Delaware corporation (the “Company”), on , 20 201__ (the “Grant Date”) ), to , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2010 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of Class A common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ per Share. Share.1 Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the date one day prior to the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this optionagreement, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Director Stock Option Agreement (Ameresco, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Emergent BioSolutions Inc., a Delaware corporation (the "Company"), on , 20 _______ (the "Grant Date") to _______, a UK resident employee, consultant or non-employee director of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's Stock Incentive Plan (the "Plan"), a total of ______ shares (the "Shares") of common stock, $0.01 0.001 par value per share, of the Company ("Common Stock") at $ $_____ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 _______ (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Director Nonstatutory Stock Option Agreement (Emergent BioSolutions Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAchillion Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on [ ], 20 2006 (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 [ ] par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Achillion Pharmaceuticals Inc)

Grant of Option. This agreement (this “Agreement”) evidences the grant by DemandwareVerastem, Inc., Inc. a Delaware corporation (the “Company”), on , 20 date (the “Grant Date”) to name, a UK resident an employee, consultant or and/or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of number shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ $price per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Verastem, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Constellation Pharmaceuticals, a Delaware corporation (the “Company”), on , 20 [ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director [ ] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2008 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive a nonstatutory stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Constellation Pharmaceuticals Inc)

Grant of Option. This agreement (hereinafter, the “Agreement”) evidences the grant by DemandwareBoston Life Sciences, Inc., a Delaware corporation (the “Company”), on April 16, 20 2007 (the “Grant Date”) to F▇▇▇▇ ▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “ParticipantOptionee”), of an option (this “Option”) to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”)herein, a total of 300,000 shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ $2.94 per Share. Unless earlier terminated, this option Option shall expire at 5:00 p.m., Eastern time, on April 15, 20 2017 (the “Final Exercise Date”). It is intended that the option Option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “ParticipantOptionee”, as used in this optionOption, shall be deemed to include any person who acquires the right to exercise this option Option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Alseres Pharmaceuticals Inc /De)

Grant of Option. This agreement evidences the grant by Demandware, Thermo F▇▇▇▇▇ Scientific Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to , a UK resident employee, consultant or director of a subsidiary to the Company [ ] (the “Participant”), a director of the Company, of an option Option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock [Name of Equity Incentive Plan Plan] (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 1.00 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option Option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option Option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this optionOption, shall be deemed to include any person who acquires the right to exercise this option Option validly under its terms. Capitalized terms used in this Agreement and not otherwise defined shall have the same meaning as in the Plan.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Thermo Fisher Scientific Inc.)

Grant of Option. This agreement evidences the grant by DemandwareOvaScience, Inc., a Delaware corporation (the “Company”), on January 5, 20 2016 (the “Grant Date”) to Harald Stock, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of 42,460 shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $9.42 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on January 4, 20 2026 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (OvaScience, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareMomenta Pharmaceuticals, Inc., a Delaware corporation (the "Company"), on [ ], 20 200[ ] (the "Grant Date") to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's 2004 Stock Incentive Plan (the "Plan"), a total of [ ] shares (the "Shares") of common stock, $0.01 0.0001 par value per share, of the Company ("Common Stock") at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Momenta Pharmaceuticals Inc)

Grant of Option. This agreement evidences the grant by DemandwareEpizyme, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident an [employee], consultant or director [consultant], [director] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2008 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Epizyme, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareSucampo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on _____ , 20 200 _____ (the “Grant Date”) to _____ , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of _____ shares (the “Shares”) of Class A common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Sucampo Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareNitroSecurity, Inc., a Delaware corporation (the “Company”), on , 20 (the 200___(the “Grant Date”) to , [an employee / a UK resident employee, consultant or director / a director] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (NitroSecurity, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareIdera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 201[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Idera Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Inc.CuraGen Corporation, a Delaware corporation (the “Company”), on , 20 [DATE] (the “Grant Date”) to , a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of (words shares) (# shares) shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ [PRICE] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on January 24, 20 2018 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Curagen Corp)

Grant of Option. This agreement evidences the grant by DemandwareEpizyme, Inc., a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.0001 par value per share, of the Company (“Common Stock”) at $ a price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). Date”).1 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Epizyme, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareAchillion Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on [ ], 20 2010 (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 [ ] par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Achillion Pharmaceuticals Inc)

Grant of Option. This agreement Agreement (including the Notice of Grant) evidences the grant on the Grant Date set forth in the Notice of Grant, by Demandware, Inc., a Delaware corporation the Company to the Participant of an option (the “Company”), on , 20 (the “Grant DateOption”) to , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2013 Stock Incentive Plan Plan, as from time to time amended (the “Plan”), a total the number of shares (Shares set forth in the “Shares”) Notice of Grant, of common stock, $0.01 1.00 par value per share, of the Company (“Common Stock”) ), at $ the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option Option shall expire at 5:00 p.m., Eastern time, on , 20 (the Final Exercise Date”)Date set forth in the Notice of Grant. It is intended that the option Option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the U.S. Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this optionOption, shall be deemed to include any person who acquires the right to exercise this option Option validly under its terms. Capitalized terms used in this Agreement and not otherwise defined shall have the same meaning as in the Plan.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Thermo Fisher Scientific Inc.)

Grant of Option. This agreement evidences the grant by Demandware▇▇▇▇▇▇, Inc., Inc. a Delaware corporation (the “Company”), on September 7, 20 2006 (the “Grant Date”) to ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of 25,000 shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $2.93 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on September 7, 20 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Nestor Inc)

Grant of Option. This agreement evidences the grant by DemandwareIdera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2008 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Non Employee Director Nonstatutory Stock Option Agreement (Idera Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware, Inc.Ophthotech Corporation, a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident an [employee, consultant or director ] [consultant] of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2007 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Ophthotech Corp.)

Grant of Option. This agreement (this “Agreement”) evidences the grant by Demandware, Inc.Penwest Pharmaceuticals Co., a Delaware Washington corporation (the “Company”), on June 21, 20 2004 (the “Grant Date”) to A▇▇▇ ▇. ▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “ParticipantEmployee”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”)herein, a total of 100,000 shares (the “Shares”) of common stock, $0.01 .001 par value per share, of the Company (“Common Stock”) at $ an exercise price of $11.06 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on June 22, 20 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “ParticipantEmployee”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Penwest Pharmaceuticals Co)

Grant of Option. This agreement evidences the grant by DemandwareBoston Life Sciences, Inc., a Delaware corporation (the "Company"), on January 6, 20 2006 (the "Grant Date") to ▇▇▇▇ ▇. ▇▇▇▇▇▇, a UK resident employee, consultant or director an executive officer of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's 2005 Stock Incentive Plan (the "Plan"), a total of 225,000 shares (the "Shares") of common stock, $0.01 par value per share, of the Company ("Common Stock") at $ $2.50 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on January 5, 20 2016 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Boston Life Sciences Inc /De)

Grant of Option. This agreement evidences the grant by DemandwareCEVA, Inc., a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2000 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern timeTime, on June 30, 20 (the “Final Exercise Date”). Unless otherwise defined herein, capitalized terms shall have the meaning ascribed to them in the Plan. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Ceva Inc)

Grant of Option. This agreement evidences the grant by DemandwareAlnylam Pharmaceuticals, Inc.Inc,, a Delaware corporation (the “Company”), on , 20 20[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2018 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [_______] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Alnylam Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by Demandware▇▇▇▇▇▇ Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on March 10, 20 2016 (the “Grant Date”) to ▇▇▇ ▇▇▇▇▇▇▇, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, part on the terms provided herein and in the Company’s 2012 2011 Stock Incentive Plan (the “Plan”), a total of 320,000 shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $0.38 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on March 9, 20 2026 (the “Final Exercise Date”). It is intended that the option evidenced by this tins agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Employment Agreement (Allena Pharmaceuticals, Inc.)

Grant of Option. This agreement evidences the grant by DemandwareArbinet thexchange, Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Arbinet Thexchange Inc)

Grant of Option. This agreement evidences the grant by Demandware, Inc.American Superconductor Corporation, a Delaware corporation (the “Company”), on , 20 200[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2004 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 .01 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (American Superconductor Corp /De/)

Grant of Option. This agreement evidences the grant by DemandwareSaucony, Inc., a Delaware Massachusetts corporation (the "Company"), on December 22, 20 2003 (the "Grant Date") to ____________, a UK resident employee, consultant or director an employee of a subsidiary to the Company (the "Participant"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 's 2003 Stock Incentive Plan (the "Plan"), a total of 100,000 shares (the "Shares") of common stockClass B Common Stock, $0.01 .331/3 par value per shareshare ("Common Stock"), of the Company (“Common Stock”) at $ $16.25 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on December 21, 20 2013 (the "Final Exercise Date"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the "Code"). Except as otherwise indicated by the context, the term "Participant", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Incentive Stock Option Agreement (Saucony Inc)

Grant of Option. This agreement (this “Agreement”) evidences the grant by DemandwareZipcar, Inc., a Delaware corporation (the “Company”), on , 20 (the “Grant Date”) to , a UK resident employee, consultant or director an employee of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2011 Stock Incentive Plan (the “Plan”), a total of shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this optionAgreement, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Zipcar Inc)

Grant of Option. This agreement evidences the grant by DemandwareIdera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20 201[ ] (the “Grant Date”) to [ ], a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2012 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.01 0.001 par value per share, of the Company (“Common Stock”) at $ $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on , 20 [ ] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Appears in 1 contract

Sources: Nonstatutory Stock Option Agreement (Idera Pharmaceuticals, Inc.)